Abiopharma

🔍 Perkins Danielle B (Executive)

Company: IP STRATEGY HOLDINGS, INC. (IPST)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 1,875 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,648.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 773 shares of Common Stock at $0.244 per share (Direct)
  Date: 2026-04-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,875.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 1,875 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,250.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock.
• F2: The reporting person relinquished the shares of Common Stock reported herein and the issuer cancelled such shares and returned them to issuer's treasury in exchange for remitting certain tax withholding obligations of the reporting person resulting from the vesting of the RSUs. As such, no shares of the issuer were sold by the reporting person.
• F3: Represents the per share closing price of the issuer's Common Stock on the applicable vesting date or, if there was no closing price on such date, the closing price on the trading date that was immediately prior to such vesting date.
• F4: On January 2, 2026, the reporting person was granted 15,000 RSUs, which vest in equal quarterly installments over a two-year period, subject to the terms of the applicable award agreement.